VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 181 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $15,475 | -26.3% | 2,094 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $21,000 | -8.7% | 2,094 | 0.0% | 0.00% | -25.0% |
| Q2 2022 | $23,000 | -23.3% | 2,094 | -21.2% | 0.00% | 0.0% |
| Q1 2022 | $30,000 | -28.6% | 2,659 | 0.0% | 0.00% | -20.0% |
| Q4 2021 | $42,000 | -8.7% | 2,659 | 0.0% | 0.01% | -16.7% |
| Q3 2021 | $46,000 | -19.3% | 2,659 | 0.0% | 0.01% | -25.0% |
| Q2 2021 | $57,000 | +42.5% | 2,659 | 0.0% | 0.01% | +33.3% |
| Q1 2021 | $40,000 | +14.3% | 2,659 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $35,000 | +94.4% | 2,659 | +42.8% | 0.01% | +100.0% |
| Q3 2020 | $18,000 | +63.6% | 1,862 | +101.7% | 0.00% | +50.0% |
| Q2 2020 | $11,000 | +10.0% | 923 | 0.0% | 0.00% | -33.3% |
| Q1 2020 | $10,000 | – | 923 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |